2026-01-10 - Analysis Report
Okay, here's a breakdown of Northrop Grumman (NOC) based on the data provided, followed by a comprehensive analysis:

**1. Return Rate Comparison:**

*   **NOC Overview:** Northrop Grumman Corp is a global aerospace and defense technology company.
*   **NOC Cumulative Return:** 41.87%
*   **S&P 500 (VOO) Cumulative Return:** 92.74%
*   **Divergence:** -50.4 (Relative Divergence: 8.7)

**Analysis:** NOC has significantly underperformed the S&P 500 over the period measured. The divergence indicates a substantial lag in returns compared to the broader market. The relative divergence of 8.7 suggests that the current divergence is near the lowest end of its historical range.

**Alpha, Beta Analysis:**

| Year       | CAGR    | MDD   | Alpha   | Beta | Cap(B) |
|------------|---------|-------|---------|------|--------|
| 2016-2018  | -6.0%   | 23.7% | -10.0%  | 0.7  | 36.7   |
| 2017-2019  | 15.0%   | 23.7% | -2.0%   | 0.7  | 51.6   |
| 2018-2020  | -25.0%  | 23.7% | -46.0%  | 0.8  | 45.7   |
| 2019-2021  | 40.0%   | 12.9% | -3.0%   | 0.7  | 58.0   |
| 2020-2022  | 18.0%   | 16.9% | 19.0%   | 0.6  | 81.8   |
| 2021-2023  | 23.0%   | 16.9% | 22.0%   | 0.3  | 70.2   |
| 2022-2024  | -14.0%  | 16.9% | -33.0%  | 0.3  | 70.4   |
| 2023-2025  | -1.0%   | 17.7% | -63.0%  | 0.1  | 85.5   |

*   **CAGR (Compound Annual Growth Rate):** Shows varying performance over different periods, including both positive and negative growth.
*   **MDD (Maximum Drawdown):** Indicates the potential for significant losses. MDD is relatively high in all periods.
*   **Alpha:** Generally negative, implying underperformance compared to the benchmark for most periods.  Positive Alpha in 2020-2022 and 2021-2023 is a notable exception.
*   **Beta:** Ranging from 0.1 to 0.8, indicating lower volatility than the market in later years, and closer to the market average in previous years.
*   **Cap(B) (Market Cap in Billions):** Shows the general size and scale of the company.

**2. Recent Stock Price Fluctuations:**

*   **Current Close:** 590.79
*    **Last-market:** {'price': 618.82, 'previousClose': 590.79, 'change': 4.74}
*   **5-day SMA:** 595.08
*   **20-day SMA:** 577.21
*   **60-day SMA:** 575.73

**Analysis:** The current price ($618.82) is above all three moving averages, suggesting a short-term upward trend. The price change suggests a sharp increase. The price bouncing back can affect moving averages with short-term SMA increasing first, followed by longer term SMA.

**3. Technical Indicators and Expected Return:**

*   **MRI (Market Risk Indicator):** 0.7 (Medium Investment Recommended)
*   **RSI (Relative Strength Index):** 59.58 (Neutral)
*   **PPO (Percentage Price Oscillator):** 0.36 (Neutral)
*   **Hybrid Signal:** cash_0%_Buy 90% of cash (1 shares - Safe - MRI:0.80) Monthly invest 0.8% of total investment ($1,000.00) (Cash Ratio: 0% on 2026-01-02)
*   **Recent (20 days) relative divergence change:** 2.9 (+): 단기상승 (Short-term increase)
*   **Expected Return (%):** -134.9 (negative excess return vs S&P 500)

**Analysis:**

*   The MRI suggests a medium level of investment risk.
*   The RSI is near 60, indicating neutral momentum (neither overbought nor oversold).
*   The positive change in relative divergence over the last 20 days confirms the short-term upward trend.
*   The *very* negative expected return compared to the S&P 500 is concerning and suggests the model projects significant underperformance if held long-term *from this point*.

**4. Recent News & Significant Events:**

*   **Trump Curbs Dividends and Executive Pay Risk:** This headline implies potential governance or financial constraints.
*   **Stocks Making Moves:** This suggests NOC is experiencing significant price fluctuations, corroborating the sharp increase in price.
*   **Analyst Price Target:** $623 price target suggests analysts believe the stock is undervalued.
*   **Earnings Report Beat Potential:** Anticipation of a positive earnings report can drive the price up.
*   **Golden Cross Signal:** A bullish technical indicator, suggesting a potential long-term uptrend.
*   **Defense Budget Caution:** Highlights potential risks associated with reliance on government spending.

**Analysis:** The news is mixed. Some news items like "Golden Cross Signal" and "Analyst Price Target" are positive. However, news regarding potential concerns surrounding Trump's policy on dividends and executive pay curb is negative. One should consider the impact of the news while considering whether to invest.

**4-2. Analyst Opinions:**

*   **Consensus:** Buy (Mean: 2.09)
*   **Target Price:** $665.20 (Average), $770.00 (High), $533.00 (Low)

**Analysis:** Analysts, on average, have a "Buy" rating on NOC and believe the stock is undervalued, with an average target price significantly higher than the current price (618.82). However, the range of target prices is wide, suggesting differing opinions on the stock's potential.

**5. Recent Earnings Analysis:**

| 날짜       | EPS   | 매출        |
|------------|-------|-------------|
| 2025-10-21 | 7.69  | 10.42 B$    |
| 2025-07-22 | 8.17  | 10.35 B$    |
| 2025-04-22 | 3.33  | 9.47 B$     |
| 2024-10-24 | 7.02  | 10.00 B$    |
| 2025-10-21 | 7.02  | 10.00 B$    |

**Analysis:**

*   **EPS (Earnings Per Share):** EPS has been volatile, with a significant dip in 2025-04-22. The recent earnings appear to be strong.
*   **매출 (Revenue):** Revenue has generally been stable, hovering around $10 Billion, with a dip in 2025-04-22.

**6. Financial Information (Revenue, Profitability, Capital):**

**Revenue and Profitability:**

| Quarter      | Revenue   | Profit Margin |
|--------------|-----------|----------------|
| 2025-09-30   | $10.42B   | 21.37%         |
| 2025-06-30   | $10.35B   | 21.35%         |
| 2025-03-31   | $9.47B    | 16.69%         |
| 2024-12-31   | $10.69B   | 18.08%         |
| 2024-09-30   | $10.00B   | 21.07%         |

**Capital and Profitability:**

| Quarter      | Equity    | ROE    |
|--------------|-----------|--------|
| 2025-09-30   | $15.99B   | 6.88%  |
| 2025-06-30   | $15.47B   | 7.59%  |
| 2025-03-31   | $14.98B   | 3.21%  |
| 2024-12-31   | $15.29B   | 8.27%  |
| 2024-09-30   | $14.75B   | 6.96%  |

**Analysis:**

*   **Revenue:** Revenue is relatively stable, with a slight dip in the 2025-03-31 quarter.
*   **Profit Margin:** Profit margins are generally healthy, mostly in the 21% range, with a dip in the 2025-03-31 and 2024-12-31 quarters.
*   **Equity:** Equity is trending upwards, indicating growth in the company's net worth.
*   **ROE (Return on Equity):** ROE fluctuates, with a low in 2025-03-31.

**7. Comprehensive Analysis (Summary):**

*   **Underperformance:** NOC has significantly underperformed the S&P 500, and the negative expected return suggests this trend could continue *from this point, if the model is accurate.*
*   **Recent Uptick:** Recent price action shows a short-term upward trend, supported by the Golden Cross signal, analyst ratings, and recent relative divergence change.
*   **Mixed News:** News is a mixed bag, with positive analyst ratings and potential earnings beats offset by concerns about policy changes and reliance on the defense budget.
*   **Solid Financials:** The company has generally stable revenue, good profit margins, and growing equity. However, ROE is volatile.
*   **Analyst Confidence:** Analysts believe the stock is undervalued with an average target price significantly higher than current price.

**Overall Assessment:**

NOC presents a mixed picture. While it has underperformed the market, recent technical indicators and analyst ratings suggest a potential for short-term gains. The negative expected return is a major concern, and investors should carefully consider the factors driving this projection.

**Disclaimer:** This analysis is based solely on the provided data and should not be considered financial advice. Any investment decisions should be made after conducting thorough research and consulting with a qualified financial advisor.


**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.